Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells (Q40877285)

24 September 2017

title

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells (English)

1 reference

24 September 2017

Firon M

1 reference

24 September 2017

Shaharabany M

1 reference

24 September 2017

Altstock RT

1 reference

24 September 2017

Horev J

1 reference

24 September 2017

Abramovici A

1 reference

24 September 2017

Resau JH

1 reference

24 September 2017

Vande Woude GF

1 reference

24 September 2017

Tsarfaty I

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

2386-2397

1 reference

Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Gene diagnostics provide new insights into breast cancer prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Expression of the C-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Overexpression of the Met/HGF receptor in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Growth Factor Synthesis and Human Breast Cancer Progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Expression of c-met is a strong independent prognostic factor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

sprouty Encodes a Novel Antagonist of FGF Signaling that Patterns Apical Branching of the Drosophila Airways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Activating mutations for the Met tyrosine kinase receptor in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Expression of scatter factor and c-met receptor in benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Expression and loss of heterozygosity of c-met proto-oncogene in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Molecular cloning and expression of human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Modulation of hepatocyte growth factor and c-met in the rat mammary gland during pregnancy, lactation, and involution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Smooth muscle releases an epithelial cell scatter factor which binds to heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Scatter factor/hepatocyte growth factor is essential for liver development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

The met proto-oncogene receptor and lumen formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

The Met proto-oncogene mesenchymal to epithelial cell conversion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203557

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203557

1 reference

Dimensions Publication ID

24 September 2017

1044365756

0 references

1 reference